Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
about
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal studyA mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.Immunopathogenesis of thyroid eye disease: emerging paradigmsGraves' ophthalmopathy: a review of immunogenetics.Graves' ophthalmopathy: state of the art and perspectives.Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapyPathogenesis of Graves' ophthalmopathy: the role of autoantibodies.Extraocular muscle autoimmunity and orbital fat inflammation in thyroid-associated ophthalmopathy.Pathogenesis of Graves' orbitopathy: a 2010 update.The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.Type XIII collagen expression is induced during malignant transformation in various epithelial and mesenchymal tumours.Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.Proteomic surveillance of putative new autoantigens in thyroid orbitopathy.
P2860
Q28255453-D9ACCA94-7893-47EB-9BB5-038186D5CB6FQ30490198-2320BD8D-60D3-473D-90E1-AAEB86DC7584Q33789467-3A5F29A0-550E-4785-A7E0-623CD8BC9570Q35731002-7E2CE596-8BE2-4E95-BCCC-B7ED549CE726Q35785171-DF9DA8F0-EF98-45D9-ACEC-9682FD0B9A35Q35921354-3762059B-0008-4123-A647-077D64F40D7CQ36437367-BA90288F-A98D-44FC-AF1C-505E6EB90540Q36970632-6B798927-A8B8-4C72-834A-0DDE398A0949Q37755309-86454A59-F17F-4675-997F-2967AFAE1298Q37772737-9BB32E07-682E-4A8B-95DF-1073D4D9260AQ37784810-AC2D4317-DED3-4F46-9251-378795F57DB6Q40383512-15CE724B-94E8-487A-BFB9-DD2BD68BEFA5Q43042591-F636BDF5-D1E1-4F0F-8C31-BCD152C3CC87Q53668615-DA3C7A09-8055-498F-9FB5-5074E61054C1
P2860
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@ast
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@en
type
label
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@ast
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@en
prefLabel
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@ast
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@en
P2093
P2860
P356
P1476
Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03345270
P577
2004-03-01T00:00:00Z